About Burhan Fakhurji
Founder of well established biotech company iGene (diagnostic for Oncology and genetics disorders) and Xgenome (Molecular Biology and Genetics innovation industry). More than 18 years of experience in Molecular Biology with a demonstrated history of working in the medical diagnostic lab at the Ministry of Health. Skilled in outbreak project planning, strong interpersonal skills with certification in employee mediation, team building and innovative problem solver.

Dr.Fakhurji graduated from medical School in 1999, he holds MSc in Molecular and cancer cell, MSc in anatomy and histology, Dip in Epidemiology in action, Dip in leadership and management and PhD in liver fibrosis.

Recently he wrote a book among Guidelines in safety regulations in medical laboratories. More than 10 publication papers in Drug design and natural product extraction, Dr. Fakhurji was present and became chairman for more than 15 scientific conferences national and international. As we as Dr. Fakhurji lead the biotech industry by establishing 2 companies and adding value as mentors for many start up companies, with a well connection with commercial funds. Finally Dr. Fakhurji got IP and patent regulations for 3 medical diagnostic kits.

About Xgenome
Xgenome is a company specializing in biotechnology, making it a technological innovation hub. It has won three local and international awards in the innovation field. Moreover, what distinguishes Xgenome is the latest laboratory equipment that enables the center to provide:

• Analysis and diagnosis services for cancer and genetic mutations with the most recent technologies.
• Identify the national genome through bioinformatics.
• Determine DNA sequences in genetic diseases by artificial intelligence application.
• Automation programmed for health care processes.
• Distinguished training programs as well as workshops that refine practical skills with a scientific background in molecular biology and technology.
• Research capabilities for, scientists to apply their experiments to medical production
• An incubator for entrepreneurship and innovation alongside co-working areas and huddle rooms.

The company is equipped with cutting-edge technology in genetic diagnostics to cater to
governmental initiatives for local e-oncology diagnosis and treatment.
The majority of the required capital will be reinvested in the company, with the aim of achieving double-digit growth in 2026